Global organoids and spheroids market was valued at US$ 905.14 million in 2023 and is projected to attain a valuation of US$ 5,581.47 million by 2032 at a CAGR of 22.42% during the forecast period 2024-2032.
The United States clinical laboratory services market is expected to reach a valuation of US$ 125.6 Bn by 2030 from 93.0 billion in 2022 at a CAGR of 4.2% over the forecast period 2023-2030.
The Global Soft tissue sarcoma (STS) Market has been estimated to grow with a CAGR of 7.4% during the forecast year and was holding a revenue of US$ 3,595.41 Mn in 2022 and is projected to reach US$ 6,465.70 Mn by 2030.
Global Medical rehabilitation services market was valued at US$ 315.6 million in 2023 and is expected to reach a valuation of US$ 600.0 million by 2032 at a CAGR of 7.4% during the forecast period of 2024–2032.
Asia Pacific stem cell therapy market was valued at US$ 1,688.04 million in 2024 and is poised to reach valuation of US$ 4,075.75 million by 2033, growing at a CAGR of 10.29% during the forecast period 2025–2033.
Exosome research market was valued at US$ 236.99 million in 2024 and is anticipated to record a revenue of US$ 1,690.88 million by 2033 at a CAGR of 24.4% over the Forecast Period of 2025 to 2033.
India specialty drug distribution market generated a revenue of US$ 2,045.35 million in 2022 and is estimated to reach a valuation of US$ 5,997.7 million by 2031 at a CAGR of 12.93% during the forecast period 2023–2031.
ASEAN nutritional supplements market generated revenue of US$ 7,366.8 million in 2022 and it is estimated to reach valuation of US$ 14,847.3 million by 2031 at a CAGR of 8.4% during the forecast period, 2023–2031.